Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Sexually Transmitted Diseases

Free Subscription Articles published in Gynecol Oncol Retrieve available abstracts of 32 articles: HTML format

Single Articles

January 2024
1. BEFANO B, Wentzensen N, Lorey T, Poitras N, et al
   Calendar-period trends in cervical precancer and cancer diagnoses since the introduction of human papillomavirus and cytology co-testing into routine cervical cancer screening at Kaiser Permanente Northern California.
   Gynecol Oncol. 2024;184:89-95.
   PubMed     Abstract available
   
   
   December 2023
2. WEBSTER EM, Ahsan MD, Kulkarni A, Penate E, et al
   Building knowledge using a novel web-based intervention to promote HPV vaccination in a diverse, low-income population.
   Gynecol Oncol. 2023;181:102-109.
   PubMed     Abstract available
   
   
   
3. VAHTERISTO M, Leinonen MK, Sarkeala T, Anttila A, et al
   Similar effectiveness with primary HPV and cytology screening - Long-term follow-up of randomized cervical cancer screening trial.
   Gynecol Oncol. 2023;180:146-151.
   PubMed     Abstract available
   
   
   November 2023
4. CHEN F, Zhang GN, Lei W, Zhou SG, et al
   Effectiveness and safety of REBACIN as a non-invasive intervention for persistent high-risk human papillomavirus infection: A real-world prospective multicenter cohort study.
   Gynecol Oncol. 2023;178:8-13.
   PubMed     Abstract available
   
   
   May 2023
5. SCHIFFMAN M, Mirabello L, Egemen D, Befano B, et al
   The combined finding of HPV 16, 18, or 45 and cytologic Atypical Glandular Cells (AGC) indicates a greatly elevated risk of in situ and invasive cervical adenocarcinoma.
   Gynecol Oncol. 2023;174:253-261.
   PubMed     Abstract available
   
   
   
6. STOLER MH, Parvu V, Yanson K, Andrews J, et al
   Risk stratification of HPV-positive results using extended genotyping and cytology: Data from the baseline phase of the Onclarity trial.
   Gynecol Oncol. 2023;174:68-75.
   PubMed     Abstract available
   
   
   March 2023
7. STOLER MH, Wright TC Jr, Parvu V, Yanson K, et al
   Detection of high-grade cervical neoplasia using extended genotyping: Performance data from the longitudinal phase of the Onclarity trial.
   Gynecol Oncol. 2023;170:143-152.
   PubMed     Abstract available
   
   
   January 2023
8. LU L, Liu T, Wang S, Li J, et al
   Joint detection of multiple HPV-testing technologies and evaluation of clinicopathological characteristics discriminate between HPV-independent and low-copy HPV-associated cervical squamous cell carcinoma (CSCC) -an analysis of 3869 cases.
   Gynecol Oncol. 2023;170:59-69.
   PubMed     Abstract available
   
   
   November 2022
9. KNAUSS T, Hansen BT, Pedersen K, Aasbo G, et al
   The cost-effectiveness of opt-in and send-to-all HPV self-sampling among long-term non-attenders to cervical cancer screening in Norway: The Equalscreen randomized controlled trial.
   Gynecol Oncol. 2022;168:39-47.
   PubMed     Abstract available
   
   
   October 2022
10. CHEN H, Xiong W, Dong X, Liu Y, et al
    Infection status and survival impact of high-risk human papillomavirus in cervical adenocarcinomas: A systematic review and meta-analysis.
    Gynecol Oncol. 2022;167:129-136.
    PubMed     Abstract available
    
    
    August 2022
11. VAHTERISTO M, Heinavaara S, Anttila A, Sarkeala T, et al
    Alternative cytology triage strategies for primary HPV screening.
    Gynecol Oncol. 2022 Aug 10. pii: S0090-8258(22)00495.
    PubMed     Abstract available
    
    
    July 2022
12. SIVARS L, Hellman K, Crona Guterstam Y, Holzhauser S, et al
    Circulating cell-free tumor human papillomavirus DNA is a promising biomarker in cervical cancer.
    Gynecol Oncol. 2022 Jul 30. pii: S0090-8258(22)00512.
    PubMed     Abstract available
    
    
    June 2022
13. SY F, Greuel M, Winkler V, Bussmann H, et al
    Accuracy of HPV testing on self-collected and clinician-collected samples for different screening strategies in African settings: A systematic review and meta-analysis.
    Gynecol Oncol. 2022 Jun 30. pii: S0090-8258(22)00416.
    PubMed     Abstract available
    
    
    
14. RASMUSSEN CL, Thomsen LT, Baandrup L, Franzmann MB, et al
    Changes in HPV prevalence in Danish women with vulvar cancer during 28 years - A nationwide study of >1300 cancer cases.
    Gynecol Oncol. 2022 Jun 21. pii: S0090-8258(22)00418.
    PubMed     Abstract available
    
    
    April 2022
15. SAND FL, Frederiksen K, Kjaer SK
    Risk of recurrent disease following conization of cervical intraepithelial neoplasia grade 3 according to post-conization HPV status and surgical margins.
    Gynecol Oncol. 2022 Apr 7. pii: S0090-8258(22)00197.
    PubMed     Abstract available
    
    
    January 2022
16. WANG J, Dong J, Zhou Y, Wang K, et al
    Performance of human papillomavirus (HPV) mRNA testing and HPV 16 and 18/45 genotyping combined with age stratification in the triaging of women with ASC-US cytology.
    Gynecol Oncol. 2022 Jan 4. pii: S0090-8258(21)01701.
    PubMed     Abstract available
    
    
    November 2021
17. ARYASOMAYAJULA C, Chanana A, Tandel M, Kwan L, et al
    The role of high-risk HPV testing in cervical cancer surveillance.
    Gynecol Oncol. 2021 Nov 23. pii: S0090-8258(21)01606.
    PubMed     Abstract available
    
    
    September 2021
18. QIN J, Shahangian S, Saraiya M, Holt H, et al
    Trends in the use of cervical cancer screening tests in a large medical claims database, United States, 2013-2019.
    Gynecol Oncol. 2021 Sep 7. pii: S0090-8258(21)01321.
    PubMed     Abstract available
    
    
    July 2021
19. CUZICK J, Du R, Adcock R, Kinney W, et al
    Uptake of co-testing with HPV and cytology for cervical screening: A population-based evaluation in the United States.
    Gynecol Oncol. 2021 Jul 9. pii: S0090-8258(21)00525.
    PubMed     Abstract available
    
    
    
20. SALVADO A, Miralpeix E, Sole-Sedeno JM, Kanjou N, et al
    Predictor factors for conservative management of cervical intraepithelial neoplasia grade 2: Cytology and HPV genotyping.
    Gynecol Oncol. 2021 Jul 2. pii: S0090-8258(21)00515.
    PubMed     Abstract available
    
    
    June 2021
21. CHATZISTAMATIOU K, Tsertanidou A, Moysiadis T, Mouchtaropoulou E, et al
    Comparison of different strategies for the triage to colposcopy of women tested high-risk HPV positive on self-collected cervicovaginal samples.
    Gynecol Oncol. 2021 Jun 28. pii: S0090-8258(21)00516.
    PubMed     Abstract available
    
    
    
22. VAN KEER S, Peeters E, Vanden Broeck D, De Sutter P, et al
    Clinical and analytical evaluation of the RealTime High Risk HPV assay in Colli-Pee collected first-void urine using the VALHUDES protocol.
    Gynecol Oncol. 2021 Jun 22. pii: S0090-8258(21)00490.
    PubMed     Abstract available
    
    
    May 2021
23. SONG F, Belinson JL, Yan P, Huang X, et al
    Evaluation of p16(INK4a) immunocytology and human papillomavirus (HPV) genotyping triage after primary HPV cervical cancer screening on self-samples in China.
    Gynecol Oncol. 2021 May 28. pii: S0090-8258(21)00410.
    PubMed     Abstract available
    
    
    March 2021
24. GIANNELLA L, Giorgi Rossi P, Delli Carpini G, Di Giuseppe J, et al
    Age-related distribution of uncommon HPV genotypes in cervical intraepithelial neoplasia grade 3.
    Gynecol Oncol. 2021 Mar 29. pii: S0090-8258(21)00263.
    PubMed     Abstract available
    
    
    
25. CHANG CL, Ho SC, Su YF, Juan YC, et al
    DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan.
    Gynecol Oncol. 2021 Mar 20. pii: S0090-8258(21)00148.
    PubMed     Abstract available
    
    
    
26. TEOH D, Hill EK, Goldsberry W, Levine L, et al
    Overcoming the barriers to HPV vaccination in high-risk populations in the U.S.
    Gynecol Oncol. 2021 Mar 8. pii: S0090-8258(21)00083.
    PubMed    
    
    
    January 2021
27. BOGANI G, Sopracordevole F, Di Donato V, Ciavattini A, et al
    High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes.
    Gynecol Oncol. 2021 Jan 26. pii: S0090-8258(21)00080.
    PubMed     Abstract available
    
    
    December 2020
28. SPINILLO A, Dominoni M, Boschi AC, Cesari S, et al
    The relationship of human papillomavirus infection with endocervical glandular involvement on cone specimens in women with cervical intraepithelial neoplasia.
    Gynecol Oncol. 2020;159:630-635.
    PubMed     Abstract available
    
    
    November 2020
29. JANSEN EEL, Ivanus U, Jerman T, de Koning HJ, et al
    The optimal HPV-screening protocol in Eastern-Europe: The example of Slovenia.
    Gynecol Oncol. 2020 Nov 13. pii: S0090-8258(20)34058.
    PubMed     Abstract available
    
    
    
30. CHODICK G, Teper GR, Levi S, Kopel H, et al
    The impact of a Facebook campaign among mothers on HPV vaccine uptake among their daughters: A randomized field study.
    Gynecol Oncol. 2020 Nov 5. pii: S0090-8258(20)34059.
    PubMed     Abstract available
    
    
    September 2020
31. KORTEKAAS KE, Bastiaannet E, van Doorn HC, de Vos van Steenwijk PJ, et al
    Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes.
    Gynecol Oncol. 2020 Sep 21. pii: S0090-8258(20)33917.
    PubMed     Abstract available
    
    
    January 2020
32. TRIMBLE CL, Levinson K, Maldonado L, Donovan MJ, et al
    A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2/3 (CIN2/3).
    Gynecol Oncol. 2020 Jan 28. pii: S0090-8258(19)31865.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Sexually Transmitted Diseases is free of charge.